亚洲字幕成人中文在线观看,日韩久久网,欧美日韩一,操日本女人逼视频,国产欧美123,久久久久av,欧美久久久久久久久中文字幕

產(chǎn)品分類(lèi)導(dǎo)航
CPHI制藥在線 資訊 引領(lǐng)醫(yī)藥行業(yè)的數(shù)字科技 | Pharma Sources Insight第六期

引領(lǐng)醫(yī)藥行業(yè)的數(shù)字科技 | Pharma Sources Insight第六期

作者:PharmaSourcesInsig  來(lái)源:CPhI制藥在線
  2023-04-28
Your FREE source of news and insights into China pharmaceutical industry!

Pharma Sources Insight

       Pharma Sources Insight

       Your FREE source of news and insights into China pharmaceutical industry, and more!

掃碼開(kāi)始閱讀 Scan to view the full contents.

掃碼開(kāi)始閱讀

Scan to view the full contents.

Pharma Sources Insight

August 2021

       Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with the leading drug-manufacturers in China which further affect the world.

       Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPhI China.

 

       Pharma Sources Insight August 2021 focuses on the following topics:

       ?BRAND STORY

       -Product Lists of Nanjing Foreign Economic & Trade Development Co., Ltd.

       ?FIGHTING AGAINST 

          COVID-19

       -Which One of the New Dosage Forms of Nasal Spray Vaccine for COVID-19 Will Be Successful?

       -Overview of COVID-19 Vaccination in Progress in China

       -Having Applied for IPO to HKEX, What to Expect on Advaccine R&D Pipelines beyond COVID-19 DNA Vaccine

       -Science of Epidemiology: Digital Technologies Shaping Our Lives

       ?GLOBAL MARKET REVIEW

       -Alzheimer’s Disease - Recent Advances in Treatment

       -India’s Pharmaceutical Industry Disruption Impacts Africa and the World

       ?PHARMA IN CHINA

       -Popular Products and Suppliers at PharmaSources.com

       -Overseas Marketing of Furmonertinib Following Avitinib and Almonertinib

       -Bispecific Antibodies – Key Developments in China

       ?INDUSTRY INSIGHT

       -A Brief Introduction About FDA Next Step Inspections

往期回顧

August 2021

Pharma Sources Insight April 2021

第五期:https://flbook.com.cn/c/UvEylKXA3d

Pharma Sources Insight January2021

第四期:https://flbook.com.cn/c/hiKJryuATA

第二十一屆世界制藥原料中國(guó)展

相關(guān)文章

合作咨詢

   肖女士    021-33392297    Kelly.Xiao@imsinoexpo.com

2006-2025 上海博華國(guó)際展覽有限公司版權(quán)所有(保留一切權(quán)利) 滬ICP備05034851號(hào)-57
咸宁市| 宜兴市| 固原市| 怀化市| 宁安市| 惠来县| 乳山市| 得荣县| 商南县| 鄯善县| 芷江| 策勒县| 西城区| 双鸭山市| 辉县市| 怀集县| 云安县| 吉林市| 敦化市| 西乌珠穆沁旗| 营山县| 遂川县| 陈巴尔虎旗| 师宗县| 湖南省| 海宁市| 乐东| 临高县| 锦屏县| 遂溪县| 乾安县| 皮山县| 赣榆县| 连南| 遂昌县| 炉霍县| 乐清市| 富民县| 屯门区| 饶平县| 丹棱县|